Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.
Hoessel R, Leclerc S, Endicott JA, Nobel ME, Lawrie A, Tunnah P, Leost M, Damiens E, Marie D, Marko D, Niederberger E, Tang W, Eisenbrand G, Meijer L.
Hoessel R, et al. Among authors: damiens e.
Nat Cell Biol. 1999 May;1(1):60-7. doi: 10.1038/9035.
Nat Cell Biol. 1999.
PMID: 10559866